Multilocus genetic risk score associates with ischemic stroke in case-control and prospective cohort studies

Stroke

Volumn 45, Issue 2, 2014, Pages 394-402

  Malik, Rainer ^a   Bevan, Steve ^b   Nalls, Michael A ^c   Holliday, Elizabeth G ^d,f   Devan, William J ^g   Cheng, Yu Ching ^h,i   Ibrahim Verbaas, Carla A ^j   Verhaaren, Benjamin F J ^j   Bis, Joshua C ^k,l   Joon, Aron Y ^m   De Stefano, Anita L ^o,p,q   Fornage, Myriam ^m,n   Psaty, Bruce M ^k,l,r   Ikram, M Arfan ^j,s   Launer, Lenore J ^c   Van Duijn, Cornelia M ^j,s   Sharma, Pankaj ^t   Mitchell, Braxton D ^h,i   Rosand, Jonathan ^g,u,v   Meschia, James F ^w   Levi, Christopher ^e,f   Rothwell, Peter M ^x   Sudlow, Cathie ^y   Markus, Hugh S ^b   Seshadri, Sudha ^o,q   Dichgans, Martin ^a,z   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

ⁱ BALTIMORE VA MEDICAL CENTER   (United States)

^j ERASMUS MEDICAL CENTER   (Netherlands)

^k UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF WASHINGTON   (United States)

^m UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

ⁿ UNIVERSITY OF TEXAS   (United States)

^o BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^q FRAMINGHAM HEART STUDY   (United States)

^r GROUP HEALTH RESEARCH INSTITUTE   (United States)

^s Netherlands Consortium for Healthy Ageing   (Netherlands)

^t IMPERIAL COLLEGE LONDON   (United Kingdom)

^u HARVARD MEDICAL SCHOOL   (United States)

^v BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^w MAYO CLINIC   (United States)

^x UNIVERSITY OF OXFORD   (United Kingdom)

^y UNIVERSITY OF EDINBURGH   (United Kingdom)

^z Germany 3 Munich Cluster for Systems Neurology   (Germany)

more..

Author keywords

Genetic; Genetics; Polymorphism; Risk assessment; Risk factors

Indexed keywords

GENETICS; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD PRESSURE; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE;

EID: 84893778384     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002938     Document Type: Article

References (47)

1. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342-344.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757.
3. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol. 2007;6:149-161.
4. Bevan S, Traylor M, Adib-Samii P, Malik R, Paul NL, Jackson C, et al. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke. 2012;43:3161-3167.
5. Dichgans M, Malik R, König IR, Rosand J, Clarke R, Gretarsdottir S, et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke November 21, 2013. doi: 10.1161/STROKEAHA.113.00270. http://stroke.ahajournals. org/content/early/2013/11/21/STROKEAHA.113.002707.long. Accessed December 21, 2013.
6. Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44:328-333.
7. Holliday EG, Maguire JM, Evans TJ, Koblar SA, Jannes J, Sturm JW, et al; Australian Stroke Genetics Collaborative; International Stroke Genetics Consortium; Wellcome Trust Case Control Consortium. Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet. 2012;44:1147-1151.
8. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44:670-675.
9. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al; Cardiogenics; CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333-338.
10. CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25-33.
11. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-109.
12. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-687.
13. Gschwendtner A, Bevan S, Cole JW, Plourde A, Matarin M, Ross-Adams H, et al; International Stroke Genetics Consortium. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol. 2009;65:531-539.
14. Williams FM, Carter AM, Hysi PG, Surdulescu G, Hodgkiss D, Soranzo N, et al; EuroCLOT Investigators; Wellcome Trust Case Control Consortium 2; MOnica Risk, Genetics, Archiving and Monograph; MetaStroke; International Stroke Genetics Consortium. Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol. 2013;73:16-31.
15. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, et al; Australian Stroke Genetics Collaborative, Wellcome Trust Case Control Consortium 2 (WTCCC2); International Stroke Genetics Consortium. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11:951-962.
16. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol. 2008;64:402-409.
17. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet. 2009;41:876-878.
18. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25:40-43.
19. Goliasch G, Kleber ME, Richter B, Plischke M, Hoke M, Haschemi A, et al. Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. Eur Heart J. 2012;33:2282-2289.
20. Ky B, French B, Levy WC, Sweitzer NK, Fang JC, Wu AH, et al. Multiple biomarkers for risk prediction in chronic heart failure. Circ Heart Fail. 2012;5:183-190.
21. Roman MJ, Kizer JR, Best LG, Lee ET, Howard BV, Shara NM, et al. Vascular biomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study. Hypertension. 2012;59:29-35.
22. Hughes MF, Saarela O, Stritzke J, Kee F, Silander K, Klopp N, et al. Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts. PLoS One. 2012;7:e40922.
23. Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, Sharma A, et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet. 2010;376:1393-1400.
24. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008;358:1240-1249.
25. Davies RW, Dandona S, Stewart AF, Chen L, Ellis SG, Tang WH, et al. Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies. Circ Cardiovasc Genet. 2010;3:468-474.
26. Stroke Genetic Risk. 23 and Me. Https://www.23andme.Com/health/ stroke/. Accessed August 2, 2013.
27. Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al; CHARGE Consortium. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2:73-80.
28. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research, Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584.
29. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121:1768-1777.
30. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106:9362-9367.
31. Wei Z, Wang K, Qu HQ, Zhang H, Bradfield J, Kim C, et al. From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet. 2009;5:e1000678.
32. Chatterjee N, Wheeler B, Sampson J, Hartge P, Chanock SJ, Park JH. Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet. 2013;45:400-405, 405e1.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population- based linkage analyses. Am J Hum Genet. 2007;81:559-575.
34. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
35. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21.
36. Lumley T, Kronmal RA, Cushman M, Manolio TA, Goldstein S. A stroke prediction score in the elderly: validation and Web-based application. J Clin Epidemiol. 2002;55:129-136.
37. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, et al. Performance of common genetic variants in breast- cancer risk models. N Engl J Med. 2010;362:986-993.
38. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008;359:2220-2232.
39. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359:2208-2219.
40. Brautbar A, Pompeii LA, Dehghan A, Ngwa JS, Nambi V, Virani SS, et al. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012;223:421-426.
41. De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, Simon KC, et al; Steering committee of the BENEFIT study; Steering committee of the BEYOND study; Steering committee of the LTF study; Steering committee of the CCR1 study. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol. 2009;8:1111-1119.
42. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753.
43. Kraft P, Hunter DJ. Genetic risk prediction-are we there yet? N Engl J Med. 2009;360:1701-1703.
44. Schulz UG, Flossmann E, Rothwell PM. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke. 2004;35:819-824.
45. Schulz UG, Rothwell PM. Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke. 2003;34:2050-2059.
46. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, et al. Genomewide association studies of stroke. N Engl J Med. 2009;360:1718-1728.
47. Meschia JF. Decoding cryptogenic cardioembolism. Ann Neurol. 2008;64:364-366.